Literature DB >> 2093696

The effect of sulphinpyrazone and alpha-tocopherol on platelet activation and function in haemodialysed patients.

A Dmoszyńska-Giannopoulou1, L Janicka, B Sokołowska, A Ksiazek, G Orłowska, K Janicki.   

Abstract

In 30 patients on chronic haemodialysis treatment the platelet activity and function were studied before and during antiplatelet therapy with alpha-tocopherol and sulphinpyrazone. In both kinds of treatment a significant decrease of ADP-induced and spontaneous aggregation was observed. Sulphinpyrazone exerts an inhibitory effect not only on platelet aggregation but also on platelet factor 3 and provokes a significant prolongation of the bleeding time.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2093696     DOI: 10.1007/BF02549745

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  12 in total

1.  Aggregation of blood platelets by adenosine diphosphate and its reversal.

Authors:  G V BORN
Journal:  Nature       Date:  1962-06-09       Impact factor: 49.962

2.  A new method for the quantitative detection of platelet aggregates in patients with arterial insufficiency.

Authors:  K K Wu; J C Hoak
Journal:  Lancet       Date:  1974-10-19       Impact factor: 79.321

3.  Functional and structural aspects of biological membranes: a suggested structural role for vitamin E in the control of membrane permeability and stability.

Authors:  J A Lucy
Journal:  Ann N Y Acad Sci       Date:  1972-12-18       Impact factor: 5.691

Review 4.  Platelet suppressive therapy in clinical medicine.

Authors:  F E Preston; M Greaves
Journal:  Br J Haematol       Date:  1985-08       Impact factor: 6.998

5.  Vitamin E. An inhibitor of the platelet release reaction.

Authors:  M Steiner; J Anastasi
Journal:  J Clin Invest       Date:  1976-03       Impact factor: 14.808

6.  Dietary supplementation with vitamin E in hyperlipoproteinemias: effects on plasma lipid peroxides, antioxidant activity, prostacyclin generation and platelet aggregability.

Authors:  A Szczeklik; R J Gryglewski; B Domagala; R Dworski; M Basista
Journal:  Thromb Haemost       Date:  1985-08-30       Impact factor: 5.249

7.  The effect of sulphinpyrazone and its metabolites on platelet function in vitro and ex vivo.

Authors:  G F Pay; R B Wallis; D Zelaschi
Journal:  Haemostasis       Date:  1981

8.  Alpha-tocopherol, a potent modulator of endothelial cell function.

Authors:  N Huang; B Lineberger; M Steiner
Journal:  Thromb Res       Date:  1988-05-15       Impact factor: 3.944

9.  Effect of alpha-tocopherol administration on platelet function in man.

Authors:  M Steiner
Journal:  Thromb Haemost       Date:  1983-04-28       Impact factor: 5.249

10.  Effect of vitamin E on platelet aggregation in diabetes mellitus.

Authors:  J Watanabe; F Umeda; H Wakasugi; H Ibayashi
Journal:  Thromb Haemost       Date:  1984-07-29       Impact factor: 5.249

View more
  1 in total

Review 1.  Antiplatelet agents for chronic kidney disease.

Authors:  Patrizia Natale; Suetonia C Palmer; Valeria M Saglimbene; Marinella Ruospo; Mona Razavian; Jonathan C Craig; Meg J Jardine; Angela C Webster; Giovanni Fm Strippoli
Journal:  Cochrane Database Syst Rev       Date:  2022-02-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.